The effect of mixed chimerism on the pace of post-transplant immune reconstitution is unknown. Using flow cytometry, recall and neo-antigen vaccine responses, and T cell receptor recombination excision circle (TREC) quantification, we evaluated phenotypic and functional characteristics of T and B cells in nine patients following non-myeloablative, HLA-identical peripheral blood stem cell transplantation for chronic granulomatous disease. Engraftment of T cell, B cell, and myeloid lineages proceeded at similar paces within each patient, but engraftment kinetics segregated patients into two groups: adults, who became full donor T cell chimeras before 6 months (rapid engrafters) and children, who became full donor T cell chimeras after 6 months or not at all (slow engrafters). Quantitative B cell recovery was achieved by 6 weeks after transplantation in children, but was delayed until 1 year in adults. a lack of response to routine vaccinations and an increased incidence of opportunistic infections. [1] [2] [3] [4] This dysfunction is a consequence of quantitative and qualitative defects in both the cellular and humoral arms of the immune system.
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Quantitative defects of the immune system after T celldepleted transplantation are characterized by varying periods of sub-normal lymphocyte subset counts. NK cells recover within 3 months after transplantation, followed by CD8 + T cells, and lastly by B cells and CD4 + T cells. [5] [6] [7] [8] [9] [10] Naive T cell recovery, which is important for the restoration of a normal T cell repertoire, is inversely proportional to age. [11] [12] [13] [14] [15] [16] Correlating with naive T cell recovery is the fact that children respond more quickly than adults to vaccination with recall antigens after transplantation. 17 Quantitative humoral defects after myeloablative transplantation include IgA, IgM, and IgG subclass deficiencies. [18] [19] [20] [21] In addition, reconstituted Ig concentrations do not necessarily coincide with functional humoral immunity. 22 Opportunistic infections during the post-transplant period contribute significantly to the morbidity and mortality of this procedure. The incidence of opportunistic infections is proportional to the degree of T cell depletion. Use of less intensive non-myeloablative marrow conditioning regimens has reduced the conditioning-related toxicity, 23, 24 but the effects on post-transplant immune recovery have not been studied in detail. Evidence of more rapid recovery of immune function following non-myeloablative allogeneic stem cell transplantation would further enhance the appeal of this approach.
The patients in this study were being treated for chronic granulomatous disease (CGD) with an allogeneic, nonmyeloablative, T cell-depleted, hematopoietic stem cell transplant using an HLA-identical sibling donor. 25 This approach allowed for the unique opportunity to study immune reconstitution in the setting of mixed hematopoietic chimerism. Analysis of several quantitative and qualitative measures of immune reconstitution in this homogeneous group of patients reveals different patterns of reconstitution for children and adults: children have slower donor engraftment than adults, but they have earlier recovery of T and B cell number and function.
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Materials and methods
Patients and protocols
Ten patients were enrolled in NIH protocol number 98-I-0104. Patient characteristics are summarized in Table 1 . Patient 3 had primary graft rejection and was excluded from all analyses. Patient 2 developed early complications with acute and later extensive chronic graft-versus-host disease (GVHD) and did not participate in the vaccine response portion of the study. Patients were conditioned with cyclophosphamide (60 mg/kg on days −7 and −6, fludarabine 25 mg/m 2 on days −5 to −1, and anti-thymocyte globulin 40 mg/kg on days −5 to −2. Cyclosporine was started on day −4 and continued at a dose to maintain therapeutic blood levels until day +100. Patients received у5 × 10 6 G-CSF mobilized CD34
+ cells/kg and 1 × 10 5 CD3 + cells from an HLA-matched sibling. Donor apheresis products were CD34
+ -selected and CD3 + -depleted using the Isolex 300i immunomagnetic bead selection system (Nexell Therapeutics, Irvine, CA, USA). To augment donor stem cell engraftment, patients received a donor lymphocyte infusion (DLI) of 2 × 10 6 CD3 + cells/kg on day +30 and 1 × 10 7
CD3
+ cells/kg on day +60 if donor CD3 chimerism was Ͻ60%. Time points for all data are relative to the day of stem cell infusion.
Donor/recipient chimerism
Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll separation. CD3
+ and CD19 + lymphocyte subsets were obtained by magnetic bead separation (Dynal, Lake Success, NY, USA). CD15 selection for neutrophils was performed on whole blood. DNA isolation of the selected cells was performed with a QIAamp mini kit (Qiagen, Valencia, CA, USA). Donor-and recipient-specific DNA microsatellite regions were amplified using either Cofiler or Profiler fluorescent primer kits (Perkin-Elmer, Foster City, CA, USA), and the amplification products were electrophoresed on a 310 Genetic Sequencer (Perkin-Elmer). Unique donor and recipient amplification products were identified and quantified using GeneScan software (Perkin-Elmer).
Enumeration of lymphocyte subsets
Anticoagulated (EDTA) whole blood samples were stained using a whole blood lysis method and analyzed on a dual laser FACSCalibur (Becton Dickinson, San Jose, CA, USA) using CellQuest software (Becton Dickinson). Control samples from healthy volunteers were analyzed concurrently with experimental samples. Lymphocytes were identified by forward and side scatter, and the lymphocyte gate was checked using the anti-CD45/anti-CD14 Leucogate reagent (Becton Dickinson). Lymphocyte subset frequencies were converted into absolute counts by multiplying the percent of stained lymphocytes by the absolute peripheral blood lymphocyte count performed by an automated counter. Reference ranges for lymphocyte subsets represent 95% confidence intervals of NIH adult, non-smoking volunteers. Antigen-specific T cell assay PBMC were isolated from whole blood 3-8 weeks after vaccination by Ficoll separation and frozen in heat-inactivated fetal calf serum (FCS)/10% DMSO. PBMC were rapidly thawed at 37°C and washed once in RPMI 1640 (Life Technologies, Rockville, MD, USA) supplemented with 10% FCS and 100 U/ml each of penicillin and streptomycin. Viable cells were counted by Trypan blue dye exclusion. 5 × 10 5 to 1 × 10 6 PBMC were added to each uncapped, tissue culture treated 16 × 125 mm tube (Corning 25200, Corning, NY, USA) in 1.5 ml of media. For each time point tested, three cultures were prepared: a negative control culture with 5 g/ml keyhole limpet hemocyanin (KLH; NIH Pharmacy, Bethesda, MD, USA; 0.004 endotoxin units/g); a culture with 5 g/ml preservative-free tetanus toxoid (University of Massachusetts Medical Center, Worcester, MA, USA; Ͻ0.002 endotoxin units/g); and a positive control culture with 1 g/ml staphylococcal enterotoxin B (SEB; Sigma Chemicals, St Louis, MO, USA). The same number of PBMC per culture were used for each time point. Cells were cultured for 6 h at 37°C and 7% CO 2 . Total RNA from the cultures was isolated using Rneasy kit (Qiagen, Valencia, CA, USA). Purified RNA was treated with 20 units/ml of amplification grade DNAse in DNAse buffer (Life Technologies) for 15 min at room temperature, followed by DNAse inactivation at 70°C for 15 min. cDNA was made with random hexamer primers and Superscript II reverse transcriptase (Life Technologies). Interleukin-2 (IL-2) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA quantification was performed with an ABI Prism 7700 using predeveloped IL-2 and GAPDH assay kits (all from Perkin Elmer). IL-2 cDNA levels were normalized to GAPDH cDNA levels in each culture by the comparative threshold cycle method using Sequence Detection software v1.6.3 (Perkin Elmer). GAPDH was selected as endogenous control because a comparison of 11 different housekeeping genes revealed that GAPDH levels varied the least over these culture conditions. A validation experiment demonstrated a 10.5% difference in amplification efficiencies of GAPDH and IL-2 cDNA per 10-fold change in cDNA concentration. The tetanus-specific IL-2 response was determined by the ratio of the relative amount of IL-2 cDNA in the tetanus toxoid culture to the relative amount of IL-2 cDNA in the KLH culture. Healthy adult volunteers were vaccinated once with hepatitis B and dT vaccines, and post-vaccination cells were collected 4 weeks after immunization.
Vaccines and antibody titers
T cell receptor recombination excision circle (TREC) quantification
Quantification of TREC in CD3
+ T cells was performed by real-time quantitative PCR using the 5′-nuclease (TaqMan) assay with an ABI7700 system (Perkin-Elmer) as previously described. 15 Briefly, PBMC were separated into a CD3 + population using magnetic microbeads (Dynal 
Statistical analyses
All analyses comparing pediatric and adult groups were computed using the two-tailed Mann-Whitney test. A P value of Ͻ0.05 was considered significant.
Results
Donor/recipient chimerism
Donor chimerism was determined in T cells, B cells, and neutrophils at 3, 6 and 12 months after transplantation. For all lineages tested, donor engraftment occurred faster in adult patients (Figure 1 ). At the 6 month time point, five of five pediatric patients were mixed chimeric in the T and B cell compartments, and four of five were mixed chimeric in the neutrophil compartment. In contrast, all adult patients had Ͼ90% donor T and B cell chimerism at 3 months and showed complete myeloid and lymphoid engraftment at 6 months. The difference in donor stem cell engraftment kinetics did not correlate with the mean CD34 + cell dose given to the two groups (10.7 × 10 6 /kg vs 6.5 × 10 6 /kg in the pediatric and adult groups, respectively). Based on these patterns, the group of pediatric patients was defined as 'slow engrafters' and the adult patients were defined as 'rapid engrafters'. Patient 6 had mixed chimerism in all lineages until 6 months, after which donor cells could no longer be detected. He is included in the analyses up to 6 months.
Lymphocyte counts
B cells recovered faster in the slow engrafter (pediatric) group, which had normal B cell counts by 1.5 months (Figure 2a) . In contrast, B cell counts remained below normal for up to 1 year in the rapid engrafter (adult) group (Figure 2a) . Although there is a difference between the pediatric and adult patients, the difference was not statistically significant due to the small sample size. At 1.5, 3, 6 and 12 months after transplantation, CD5
+ B cells accounted for a median of 97%, 83%, 85%, and 85% of total B cells in the slow engrafters, respectively, and 76% of total B cells in the rapid engrafters at 12 months.
Median CD4 + T cell counts remained below normal up to 1 year after transplantation in both groups (Figure 2b) . At 12 months, the slow engrafters showed an upward trend, reaching a normal median number of CD4 + T cells. The increase in CD4 + T cells of slow engrafters was largely due to the emergence of naive T cells, as shown by an increased expression of CD45RA (Figure 2c ). CD45RO expression on CD4 + T cells remained constant through the first 12 months in both groups (Figure 2d ). This expression was not influenced by periodic infusions of donor lymphocytes. In contrast to CD4 + T cells, median CD8 + T cell counts recovered to the normal range by 3 months in both groups (Figure 2e) . For both the slow and fast engrafters, median NK cell counts peaked at 1 month (Figure 2f) .
TREC quantification
Quantification of T cell receptor recombination excision circle signal joints is a measure of thymopoietic capacity. 15 TREC counts greatly complement immunophenotypic identification of naive T cells that have recently left the thymus or that have remained in the periphery without significant division. Figure 3 shows a trend towards more TREC positive CD3 + cells at 3 months post transplant in the pediatric group with slow engraftment as compared to the adult group with rapid engraftment. This difference in TREC recovery for rapid and slow engrafters became significant at 6 months (P = 0.02). At 12 months, there was no significant difference between groups. It should be noted that the TREC analysis was performed on CD3 + cells and therefore reflects the emergence of naive CD4 + and CD8 + T cells. 
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Quantitative immunoglobulin levels
Levels of IgG, IgA, IgM, and IgG subclasses were quantified at 3, 6 and 12 months after transplantation (Table 2) . In both groups, Ig concentrations were at normal levels when first tested at 3-4 months.
Qualitative lymphocyte recovery
The pre-and post-vaccination TT-specific antibody titers and TT-specific T cell responses are shown in Figure 4a and b. T cell responses were defined as a relative increase in IL-2 mRNA attributable to TT stimulation. Median TTspecific IL-2 mRNA increases from five previously vaccinated normal volunteers were 6.9-fold pre-TT boost and 13.7-fold post-TT boost (data not shown). No patient had an increase in TT-specific antibody titer after the 3 month vaccination, which followed the cyclosporine taper. At 6 months, TT-specific T cells were detected in three of four pediatric patients (median 10.2-fold increase in IL-2 mRNA), but only one of those four patients had a greater than two-fold increase of anti-tetanus antibody titer. All pediatric patients had evidence of antigen-specific T cells and a robust boost of anti-TT antibodies at 12 months.
None of the adult patients tested had evidence of TTspecific T cells or a significant increase in antibody titers after the 3-and 6-month TT boosters. After the 12-month booster, both adult patients showed trends towards TTspecific T cell responses. Patient 5, who had the greater T cell response, was able to boost his anti-TT antibody titers. Table 3 shows the antibody responses to hepatitis B surface antigen, a neo-antigen for both donors and recipients. Pediatric patients begin to show responses to the neoantigen at 3 months, whereas no adult tested had an antibody response for the first year post transplant. 
Discussion
This study characterizes immune reconstitution after T celldepleted allogeneic hematopoietic stem cell transplantation using non-myeloablative conditioning. The patient population consisted of individuals who had CGD, an inherited phagocyte disorder not known to affect T and B cell function, and who had not received cytotoxic and/or immunosuppressive therapy prior to transplantation. Little is known about immune reconstitution following this approach to allogeneic transplantation, which frequently results in prolonged mixed hematopoietic chimerism. Immune reconstitution in this particular setting depends on three potential sources of functional lymphocytes: (1) residual host lym-phocytes that survived the conditioning regimen; (2) naive, stem cell-derived lymphocytes of both donor and host origin; and (3) mature donor lymphocytes transfused during delayed lymphocyte add-back, as part of our transplant protocol. In this analysis, we demonstrate that age is an important determinant in the kinetics of donor stem cell engraftment and that younger patients with slow engraftment kinetics have more rapid quantitative and qualitative reconstitution of T and B lymphocytes. Donor/recipient chimerism analysis revealed that T cell, B cell, and myeloid lineages engraft in similar patterns and that the switch to full donor chimerism occurs in pediatric patients after 6 months, if at all, and by 3 months in adult patients. Moreover, pediatric recipients were more likely to remain mixed chimeric at 12 months than adult recipients. These results are consistent with the finding that older age increases the degree of donor chimerism. 26 It should be noted that although we have defined adults as age у18, our adult population is relatively young (median age, 29 years).
In contrast to previous studies, in which pre-transplant thymic integrity might have been compromised, either because of prior cytotoxic agent-induced damage or because of the underlying immunodeficiency disorder, this study allowed a relatively unaffected evaluation of the relationship between age and thymic function. The data presented here confirm the finding that naive T cell recovery is inversely proportional to age. Normalization of CD4 + /CD45RA + T cells in the (pediatric) slow engrafters, together with the trend towards more TREC-positive T cells in this group, support the role of the thymus in naive T cell reconstitution. 27 It is possible that expansion of memory cells causes an apparently low thymic output by diluting TREC levels in adult patients. However, their absolute CD4 + /CD45RA + T cell counts are depressed. It should also be noted that post-transplant immunosuppression does not decrease TREC counts. 28 The combination of low TREC levels with low absolute CD4 + /CD45RA + T cell counts demonstrates low thymic output in the adults for the first 6 months after transplantation. At the same time in the adult patients, CD8
+ T cells expand rapidly by 6 months after transplantation. This expansion, coupled with the observation of more extensive clinical GVHD in the adults, supports the theory that expansion of memory cells mediates GVHD, which in turn inhibits thymic output.
With regard to the accelerated quantitative recovery of B cells in slow engrafters, data from other pediatric series show that quantitative B cell reconstitution is faster in children than in adults. [7] [8] [9] [10] [29] [30] [31] In addition, allograft characteristics and conditioning regimens have been shown to affect B cell recovery. Small et al 5 showed that B cell recovery is accelerated after T cell-depleted stem cell transplants. CD4 + and CD8 + T cells and NK cells recover in patterns similar to those described following conventional allogeneic transplantation.
5-10,31 CD4 + T cell counts remain low up to 1 year after transplantation, but CD8 + T cells recover by 3 months. In all of our patients, NK cell counts increase to levels above baseline within 1 month after transplant and then return to baseline levels.
To test T cell function, we developed an antigen-specific T cell assay based on IL-2 quantification after short-term antigen stimulation. Using this assay, we found that funcBone Marrow Transplantation tional T cell reconstitution occurred more quickly in the younger patients who had slower donor stem cell engraftment kinetics. Surprisingly, only two of four pediatric patients with a normal T cell response to TT had a greater than two-fold increase in anti-TT antibodies. This discordance between T cell and B cell responsiveness corrects by 12 months in the pediatric patients, but not in adult patients. This is consistent with the finding of an agedependent recovery of T cell function as measured by proliferation assays using PHA and anti-CD3 antibody. 5 Overall, our T cell assay demonstrates that antigenspecific T cell recovery precedes, or occurs simultaneously with, antigen-specific antibody development. The rise in neo-antigen-specific antibody titers (antibodies to hepatitis B surface antigen) in several patients corresponds with the rise in recall antigen-specific T cells. It should be noted that overall, the children received more DLI than the adults, so adoptive transfer of antigen-specific immunity is possible. Furthermore, qualitative differences may exist between DLI derived from pediatric donors and DLI derived from adult donors. The primary difference in the T cell subsets between children 4-8 years old and adults 24-59 years old is a slightly lower CD4/CD8 ratio (2.09 vs 1.44, respectively). 32 As a result, the pediatric recipients may have received more CD4 + cells than the adults with each DLI. The DLI of all donors contributed mostly mature T cells, as we did not detect a change in circulating TREC levels following any of the DLI (data not shown). In addition, the frequency of memory B cells specific for the vaccines that were tested may have been higher in the DLI from pediatric donors due to more recent vaccination.
Subclinical GVHD may explain the observed differences in immune reconstitution between children and adults. Clinical GVHD decreases TREC counts, indicating an effect on thymic function, and it also decreases B cell counts. 28, 33 These effects may also extend to subclinical GVHD. We and others have observed an increased frequency and severity of GVHD in adult compared to pediatric patients (Table 1) . 34 Protection from severe GVHD is derived in part from the prolonged mixed chimeric state seen in our pediatric patients. Conversely, the rapid engraftment kinetic observed in our adult patients is more conducive to the development of clinical or subclinical GVHD resulting in impaired immune reconstitution.
Non-myeloablative allogeneic transplantation regimens reduce transplant-related morbidity and constitute a promising mode of transplantation for diseases such as CGD. [23] [24] [25] Prolonged mixed chimerism in pediatric patients following non-myeloablative stem cell transplantation appears to be advantageous for immune reconstitution. This advantage may be derived from residual immune-competent host T cells that survived the conditioning regimen. A prospective study of the origin of post-transplantation antigen-reactive T cells in patients with mixed chimerism may elucidate this point. Other possibilities are that age alone or age combined with less GVHD are the most important factors in rapid immune reconstitution. Assessment of functional immunity through serial revaccination, in addition to being a recommended practice, proved a valuable tool in characterizing the pace of immune reconstitution. In combination with TREC analysis, revaccination may shed more light on the role of the thymus and the possible existence of a subclinical GVH reaction.
